ResMed Inc. (RMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RMD Revenue Growth
Revenue Breakdown (FY 2024)
RMD's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
RMD Revenue Analysis (2014–2025)
As of May 8, 2026, ResMed Inc. (RMD) generated trailing twelve-month (TTM) revenue of $5.54 billion, reflecting strong growth of +10.8% year-over-year. The most recent quarter (Q3 2026) recorded $1.43 billion in revenue, up 0.6% sequentially.
Looking at the longer-term picture, RMD's 5-year compound annual growth rate (CAGR) stands at +11.7%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $5.15 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows RMD's business is primarily driven by Sleep And Respiratory (88%), and Software As Service (12%). With over half of revenue concentrated in Sleep And Respiratory, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including PHG (-1.0% YoY), ITGR (+6.0% YoY), and NVCR (+8.5% YoY), RMD has outperformed the peer group in terms of revenue growth. Compare RMD vs PHG →
RMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RMDCurrent | $5.5B | +10.8% | +11.7% | 32.7% | |
 PHG | $17.8B | -1.0% | +0.6% | 8.0% | |
 ITGR | $1.8B | +6.0% | +11.5% | 11.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 INSP | $912M | +8.9% | +51.2% | 5.6% | |
 TNDM | $1.0B | -6.8% | +15.3% | -7.7% |
RMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.15B | +9.8% | $3.05B | 59.4% | $1.69B | 32.7% |
| 2024 | $4.69B | +10.9% | $2.66B | 56.7% | $1.32B | 28.2% |
| 2023 | $4.22B | +18.0% | $2.36B | 55.8% | $1.13B | 26.8% |
| 2022 | $3.58B | +11.9% | $2.02B | 56.6% | $1.00B | 28.0% |
| 2021 | $3.20B | +8.1% | $1.84B | 57.5% | $903.7M | 28.3% |
| 2020 | $2.96B | +13.4% | $1.72B | 58.1% | $809.7M | 27.4% |
| 2019 | $2.61B | +11.4% | $1.54B | 59.0% | $579.3M | 22.2% |
| 2018 | $2.34B | +13.2% | $1.36B | 58.2% | $541.8M | 23.2% |
| 2017 | $2.07B | +12.4% | $1.20B | 58.1% | $425.8M | 20.6% |
| 2016 | $1.84B | +9.5% | $1.07B | 58.0% | $429.0M | 23.3% |
Full RMD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRMD — Frequently Asked Questions
Quick answers to the most common questions about buying RMD stock.
Is RMD's revenue growth accelerating or slowing?
RMD maintains +10.8% revenue growth, in line with its 5-year CAGR of +11.7%. TTM revenue stands at $5.5B. Growth rate remains consistent with historical average.
What is RMD's long-term revenue growth rate?
ResMed Inc.'s 5-year revenue CAGR of +11.7% reflects the sustained expansion pattern. Current YoY growth of +10.8% is near this long-term average.
How is RMD's revenue distributed by segment?
RMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.